Quantification Hands-on Workshop (DaTQUANT) Ioflupane (123I) - 20 years of DaT-SPECT imaging

Organized by GE Healthcare

Virtual Event -“Throughout the event the speakers will be available for Q&As”

Quantifying Ioflupane (123I) images using DaTQUANT™

DaTQUANT™ is a software tool that enables visual evaluation providing automated, reproducible, and accurate quantification capabilities. This semiquantitative “Hands on Experience” will provide insights focused on: • More ways to manually adjust the ROI placement, • Importing compressed DICOM data from PACS, • Customizing normal database graphs and table of quantified values • Easier comparison of serial/longitudinal studies of the same subject

Ioflupane (123I) - 20 years of DaT- SPECT imaging

Markedly abnormal Ioflupane (123I), in one or both putamina is the diagnostic pattern for PD in patients with clinically confirmed PD. This pattern which has been helping to confirm the diagnosis in patients with unclear clinical presentations since 2000 will be presented and discussed in our round table with our guests.

We are looking forward to your participation!

Your GE Healthcare Team

Scientific Agenda

09:50 - 10:00  Welcome and Introduction

10:00 - 10:30  Diagnostic Imaging of Parkinson‘s Disease.What does the neurologist expect?

                        Dr. Athanasios Leonardos

10:30 - 11:00  Step Forward into Imaging with Ioflupane (123I)

                        Dr. Athanasios Natsios

11:00 - 12:30  DaT-SPECT - The value of a fast, effective and reproducible quantification

                        Bert Umland-Seidler

12:30 - 13:30  Break 

13:30 - 15:00  Hands-on training

                        Bert Umland-Seidler

15:00 - 15:15  Q/A coffee break

15:15 - 16:45  Round table: Ioflupane (123I) - 20 years of DaT-SPECT imaging

                        Prof. Andreas Fotopoulos

                        Dr. Athanasios Leonardos

                        Bert Umland-Seidler, Application Specialist GEHC

                        Charalampos Bougias RT, MSc

16:45 - 17:00  Summary & Conclusions  

Speakers

1. Andreas Fotopoulos, Professor of Nuclear Medicine, Ioannina University, Greece

2. Athanasios Leonardos, Movement Disorders Neurologist, National and Kapodistrian University of Athens, Division of Neurology I, Eginitio Hospital, Athens

3. Athanasios Natsios, Medical Advisor SEE, GE Healthcare LSCI

4. Bert Umland-Seidler, Application specialist GE Healthcare

5. Charalampos Bougias, RT, MSc, Nuclear Medicine Department, Ioannina University, Greece